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Abstract
Background: The rapid HIV antibody test is the diagnostic tool of choice in low and middle-income countries.
Previous evidence suggests that rapid HIV diagnostic tests may underperform in the field, failing to detect a
substantial number of infections. A research study inadvertently discovered that a clinic rapid HIV testing process
was failing to detect cases of established (high antibody titer) infection, exhibiting an estimated 68.7% sensitivity
(95% CI [41.3%-89.0%]) over the course of the first three weeks of observation. The setting is a public service clinic
that provides STI diagnosis and treatment in an impoverished, peri-urban community outside of Cape Town, South
Africa.
Methods: The researchers and local health administrators collaborated to investigate the cause of the poor test
performance and make necessary corrections. The clinic changed the brand of rapid test being used and later
introduced quality improvement measures. Observations were made of the clinic staff as they administered rapid
HIV tests to real patients. Estimated testing sensitivity was calculated as the number of rapid HIV test positive
individuals detected by the clinic divided by this number plus the number of PCR positive, highly reactive 3
rd
generation ELISA patients identified among those who were rapid test negative at the clinic.
Results: In the period of five months after the clinic made the switch of rapid HIV tests, estimated sensitivity
improved to 93.5% (95% CI [86.5%-97.6%]), during which time observations of counselors administering tests at the
clinic found poor adherence to the recommended testing protocol. Quality improvement measures were
implemented and estimated sensitivity rose to 95.1% (95% CI [83.5%-99.4%]) during the final two months of full
observation.
Conclusions: Poor testing procedure in the field can lead to exceedingly low levels of rapid HIV test sensitivity,
making it imperative that stringent quality control measures are implemented where they do not already exist.
Certain brands of rapid-testing kits may perform better than others when faced with sub-optimal use.
Background
T h ea v a i l a b i l i t yi nl o wa n dm i d d l ei n c o m ec o u n t r i e so f
effective medication for HIV in the form of highly active
antiretroviral therapy has created the need for efficient
and accurate HIV testing programs to identify candi-
dates for treatment [1]. HIV testing also remains critical
to prevention efforts as well as programs providing psy-
chological support. The rapid HIV antibody test, per-
formed on whole blood collected from a finger prick, is
the diagnostic tool of choice due to low cost, relative
ease of use, and speed in obtaining results [2]. Current
WHO guidelines for the use of rapid HIV testing in
resource constrained settings recommend the use of
rapid-test kits with >99% sensitivity and there are a
number of available options with this level of accuracy
[1].
There is evidence, however, to suggest that rapid test
kits may underperform in the field, failing to detect a
substantial number of infections. A recent study from
KwaZulu-Natal, South Africa found that the sensitivity
of four different rapid tests kits when administered by
nurses at antenatal sites was 92.5-97.3%, and 100% when
performed by laboratory technicians (compared with
ELISA gold standard) [3]. A 2008 South African
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descriptions of unreliable rapid test results in local
healthcare facilities, found that weakly positive results
could be difficult to correctly interpret and might lead
to false negative diagnoses in the field. Yet rapid test
sensitivity in the field can be excellent when properly
monitored: in four African countries that perform rou-
tine laboratory retesting of a portion of field results sen-
sitivity has ranged from 98.1% to 99.7% [4].
WHO has acknowledged the need for ongoing quality
control and assessment measures in the guidelines for
country-based implementation of rapid HIV testing.
These guidelines recommend competency assessments
of personnel who perform the tests, site visits to observe
testing, and external quality assurance based on retest-
ing a proportion of specimens by reference laboratories
[5]. Yet there is a widely held assumption among health
administrators that the user-friendly rapid tests are as
reliable and accurate in the field as in the laboratory,
requiring little monitoring to ensure the quality of
results. A 2007 review of eleven African countries with
rapid testing programs found that only seven had a sys-
tem involving laboratory retesting, four conducted peri-
odic on site observations, and two utilized proficiency
panel testing [4].
We report on the poor sensitivity of rapid HIV tests in
the field and the contrasting performance of different
testing kits. It is our hope that this account will chal-
lenge the assumption that quality control around HIV
testing need not be a high priority, lending urgency and
perspective to ongoing efforts to establish quality con-
trol measures in resource constrained settings.
Methods
This report is from a public service clinic in an informal
settlement area of Cape Town, South Africa. Unemploy-
ment there is high and many people live in abject pov-
erty: 25% of households report having no income and
over 50% of houses are informal dwellings or shacks
[6,7]. Antenatal HIV prevalence was 32.6% for the dis-
trict in 2005. There are significant barriers to the opti-
mal delivery of HIV testing services at clinics including
high staff attrition rates, insufficient in-service training
for new staff, and large numbers of patients.
From August 2008 through March 2009, the MRC
AHI study (approved by the Ethics Review Committee
of University of Cape Town) performed surveillance for
acute stage HIV infection among patients testing for
HIV at the clinic. The clinic routinely offers voluntary
HIV testing using a serial testing algorithm, whereby
one rapid test is administered and a second test is used
for confirmation of a positive result.
Adults (≥ 18 yrs) who were rapid antibody test nega-
tive or inconclusive during routine clinic testing were
referred to the study. Following informed consent, blood
was taken for further testing using HIV-1 DNA PCR
(Roche Amplicor). PCR positive samples were then
tested with a 3
rd generation HIV ELISA (Dade Behring)
to quantitatively evaluate antibody levels.
Patients who were PCR positive with zero to moderate
ELISA reactivity were classified as having acute HIV
infection, which describes the first weeks to months of
infection. Rapid tests may fail to detect individuals dur-
ing this time owing to low levels of HIV antibody [8].
Soon after beginning the study, however, we unexpect-
edly discovered patients referred to us by the clinic
health workers with negative rapid test results who were
PCR positive and strongly ELISA reactive for HIV.
These individuals had established (non-acute) HIV
infections and should have been detected 99-100% of
the time by rapid testing in the clinic, according to the
rapid test package insert. Retesting of the blood samples
in the laboratory with rapid tests yielded positive results.
A 2008 South African government report, commis-
sioned in response to descriptions of unreliable rapid
test results in local healthcare facilities, found that
weakly positive rapid test results could be difficult to
correctly interpret and might lead to false negative diag-
noses in the field. For this reason, a change in the test
brand had already been planned. This change occurred
three weeks following the beginning of our observations.
The names of the two tests are withheld for the purpose
of this report. It is the second of these that was used for
all laboratory retesting with rapid tests as explained
above.
During the month following the change in rapid tests,
two clinic testing personnel were evaluated for adher-
ence to proper protocol (as specified in package inserts)
while performing rapid testing five times each on real
patients. The regional manager of the clinic subse-
quently ordered additional testing quality improvement
measures for all area clinics, which occurred five months
after the change in rapid tests. These measures consisted
of retraining of staff in the use of rapid HIV tests, distri-
bution of an illustrated guide with clear instructions for
test use, and the introduction of electronic timers to
accurately measure when results should be read.
We are reporting on the clinic’ss e q u e n t i a lu s eo ft w o
different brands of rapid test kits and over a period
before and after quality improvement measures. By
detecting cases of established HIV infection among
those diagnosed as HIV negative by the routine clinic
testing procedure, we were able to estimate testing sen-
sitivity for different time periods. Estimated testing sen-
sitivity was calculated as the number of rapid HIV test
positive individuals detected by the clinic divided by this
number plus the number of patients with established
infections identified among those who were rapid test
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enrolled in the research study were tested as part of our
study. Thus, it is probable that cases of established HIV
infection went undetected, making our observed sensi-
tivities high estimates.
Results
In the period preceding the switch of rapid test kits,
estimated sensitivity was 68.7% (see table 1). After the
clinic began to use the new rapid test kits, testing sensi-
tivity appears to have improved. Observed sensitivity
was 93.5% over five months. At this point retraining of
staff and the introduction of quality improvement mea-
sures occurred and observed sensitivity improved
slightly to 95.1% over the final two months of
observation.
Conditions of storage were found to be adequate
throughout the entire period of the study. Observations
shortly after the change in rapid tests identified several
problems that could conceivably result in a false nega-
tive result:
*Technique - Use of a capillary tube to apply blood to
the kits and proper administration of the chase buffer
was inconsistent;
*Time for reading of results - The package insert of
the rapid tests in use states that at least 15 minutes be
allowed to pass between the application of patient blood
and the reading of results. This only occurred in 1 of 10
observed cases and the waiting time was above 10 min-
utes in only 3 cases.
Discussion
We observed a period during which rapid HIV testing
sensitivity at a clinic offering routine-testing services
was estimated at 68.7% (95% CI [41.3%-89.0%]). At a
later date, observations were made of poor testing prac-
tices on the part of clinic staff. Because staff remained
t h es a m ed u r i n gt h i st i m ep e r i o dw eh y p o t h e s i z et h a t
poor adherence to protocol explains the low test
sensitivity.
After the change in rapid test kits, and before any re-
training or quality improvement measures were imple-
mented, there was a sizeable increase in observed testing
sensitivity. This suggests there is variation among tests
in accuracy under conditions of suboptimal use. In over-
burdened and under resourced settings, rapid tests will
not always be administered in perfect accordance with
recommended protocol. Future research should compare
different rapid test kits as used in the field and deter-
mine the true operating characteristics of these tools.
The sample size in this study for the use of the first
test kit is small because of the short time period
between the beginning of observation and the change of
rapid tests. This study was not originally designed to
compare rapid test kits and we can make no recommen-
dations regarding the use of one test kit compared with
another.
Conclusions
In 2008, over 9,000 individuals were diagnosed with HIV
in clinics in the community from which we are report-
ing. If testing sensitivity during this time was the high
end of the 95% CI of our observations before any
changes were made (89.0%), more than 1,100 additional
HIV positive individuals received negative results. These
people have lost the ability care properly for themselves,
access treatment, and protect their sexual partners.
The chance detection of poor test performance in the
clinic where we were working allowed steps to be taken
which led to subsequent improvements in sensitivity. In
the context of other evidence of poor rapid test perfor-
mance in the field, our findings support an urgent call
for the implementation of stringent quality control and
assurance measures where they do not already exist.
These measures should include routine laboratory
retesting of a random sample of rapid test results and
evaluation of adherence to testing protocol on the part
of field staff.
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Table 1 Estimated rapid-test sensitivity during three periods of observation
Test Used at Clinic Total testing
at clinic
Total Testing
Positive at Clinic
Eligible Participants
Enrolled in Study (%)
Established HIV infections
detected by PCR/ELISA
Observed Testing
Sensitivity (95% CI)
Test Brand 1 69 11 82.7% 5 68.7% (41.3%-89.0%)
Test Brand 2
(before quality
improvement measures)
759 87 65.9% 6 93.5% (86.5%-97.6%)
Test Brand 2
(following quality
improvement measures)
349 39 80.2% 2 95.1% (83.5%-99.4%)
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